Protein arrays for biomarker discovery in lupus

Citations Over TimeTop 22% of 2015 papers

Abstract

Lupus is one of the most common autoimmune diseases, yet many mechanisms of its pathogenesis are not fully known. Over the last few years, advances in protein array technology have accelerated rapidly, resulting in many promising insights toward the discovery of novel lupus biomarkers that may become useful in disease diagnosis and management. Still, only two types of analytical protein arrays thus far, being antibody and antigen arrays, have found notable usage toward lupus biomarker discovery. In this review, we summarize current protein array technologies being used for biomarker discoveries in lupus and associated biomarker findings, as well as protein arrays that are likely to be used for lupus biomarker discovery in the near future.

Related Papers

• → Protein arrays for biomarker discovery in lupus(2015)13 cited
• → Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease(2012)13 cited
• → Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers(2004)46 cited
• Cancer biomarker discovery from serum based on protein microarray(2012)
• Biomarker Discovery in Cancer and Autoimmunity using an Affinity Proteomics Platform - a Tool for Personalized Medicine(2013)